Adverse events which required suspension of treatment were evaluated. The most frequently occurring adverse events were gastrointestinal OR 4.83:0.6038.6795% IC.
Se evaluaron los eventos adversos que eran suficientes para suspender el tratamiento, los más frecuentes fueron los gastrointestinales OR = 4,83 IC 95%: 0,60-38,67.